Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-22
DOI
10.1038/srep43005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The development of RAPTA compounds for the treatment of tumors
- (2016) Benjamin S. Murray et al. COORDINATION CHEMISTRY REVIEWS
- Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A
- (2016) Chiara Pelillo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
- (2015) Andrea Weiss et al. ANGIOGENESIS
- Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process
- (2015) L. Brescacin et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Erlotinib-Cisplatin Combination Inhibits Growth and Angiogenesis through c-MYC and HIF-1α in EGFR-Mutated Lung Cancer In Vitro and In Vivo
- (2015) Jasmine G. Lee et al. NEOPLASIA
- The chicken chorioallantoic membrane model in biology, medicine and bioengineering
- (2014) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation
- (2014) Neil J. Ganem et al. CELL
- Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer
- (2014) Alberta Bergamo et al. INVESTIGATIONAL NEW DRUGS
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
- (2014) Andrea Weiss et al. Chemical Science
- Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
- (2014) Zenita Adhireksan et al. Nature Communications
- The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
- (2013) Petra Heffeter et al. EUROPEAN JOURNAL OF CANCER
- Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
- (2013) Alexey A. Nazarov et al. Scientific Reports
- Gefitinib (ZD1839) increases the efficacy of cisplatin in ovarian cancer cells
- (2012) Tsuyoshi Ohta et al. CANCER BIOLOGY & THERAPY
- Designing organometallic compounds for catalysis and therapy
- (2012) Anna Louisa Noffke et al. CHEMICAL COMMUNICATIONS
- Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
- (2012) A. W. Griffioen et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy
- (2012) Samir E. Witta et al. JOURNAL OF CLINICAL ONCOLOGY
- The possible role of chemotherapy in antiangiogenic drug resistance
- (2012) Guido Bocci et al. MEDICAL HYPOTHESES
- Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?
- (2011) Anne Q. Reuwer et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
- (2010) Petra Heffeter et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways
- (2010) F. Yang et al. MOLECULAR CANCER RESEARCH
- The Neovessel Occlusion Efficacy of 151-Hydroxypurpurin-7-Lactone Dimethyl Ester Induced with Photodynamic Therapy
- (2010) Siang Hui Lim et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization
- (2009) Patrick Steigemann et al. CELL
- In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
- (2009) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model
- (2009) Patrycja Nowak-Sliwinska et al. MICROVASCULAR RESEARCH
- Bioorganometallic chemistry—from teaching paradigms to medicinal applications
- (2008) Christian G. Hartinger et al. CHEMICAL SOCIETY REVIEWS
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Classification of chromosome segregation errors in cancer
- (2008) David Gisselsson CHROMOSOMA
- The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways
- (2008) Soumya Chatterjee et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Antitumour metal compounds: more than theme and variations
- (2007) Michael A. Jakupec et al. DALTON TRANSACTIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started